Literature DB >> 25698248

The multi-targets integrated fingerprinting for screening anti-diabetic compounds from a Chinese medicine Jinqi Jiangtang Tablet.

Yan-Xu Chang1, Ai-Hua Ge2, Sineeporn Donnapee3, Jin Li3, Yang Bai4, Jiao Liu4, Jun He3, Xi Yang3, Li-Jiao Song4, Bo-Li Zhang3, Xiu-Mei Gao5.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Jinqi Jiangtang Tablet is a traditional Chinese anti-diabetic formula containing three ingredients: Coptis chinensis Franch. (dried rhizome of C. chinensis Franch., Coptis deltoidea C. Y. Cheng et Hsiao and Coptis teeta Wall.), Astragalus membranaceus (Fisch.) Bunge. (dried root of A. membranaceus (Fisch.) Bge. var. mongholicus (Bge. ) Hsiao and A. membranaceus (Fisch.) Bge. ) and Lonicera japonica Thunb. (dried alabastrum or with nascent flowers of L. japonica Thunb. ). Free radicals, α-glucosidase, α-amylase, aldose reductase and lipase are different targets related with diabetes. However, there are no chromatographic methods employed in screening the anti-diabetic compounds from natural products basing on these targets simultaneously. The present study was aimed at the establishment of a multi-targets integrated fingerprinting to clarify the possible mechanism of the action of Traditional Chinese Medicines which simultaneously contained multiple chemical characteristics and effects of constitutions.
MATERIALS AND METHODS: The multi-targets integrated fingerprinting was developed and validated to screen anti-diabetic compounds from natural products by using ultra-high-performance liquid chromatography/quadruple-time-of-flight mass spectrometry, fraction collector and microplate reader. Ultra performance liquid chromatography was employed to separate the components in Jinqi Jiangtang Tablet, which were identified by quadruple-time-of-flight mass spectrometry to acquire their structural information and collected by the fraction collector. Finally the active fractions were tested for scavenging 1, 1-diphenyl-2-picrylhydrazyl radical and inhibition of α-glucosidase, α-amylase, aldose reductase, and lipase activities in vitro by microplate reader.
RESULTS: Our tests revealed that the Jinqi Jiangtang Tablet showed inhibitory activity against α-glucosidase, α-amylase, aldose reductase and lipase with IC50 values of 0.80 ± 0.02 mg/mL, 1.28 ± 0.13 mg/mL, 0.80 ± 0.02 mg/mL, 1.90 ± 0.18 mg/mL respectively and the scavenging activity with IC50 value of 1.71 ± 0.178 mg/mL. The bioactive fractions were identified to be alkaloids, flavonoids and phenolic acids. The phenolic acids possessed antioxidant activities, namely the scavenging effect on 1, 1-diphenyl-2-picrylhydrazyl rull;). The alkaloids exhibited inhibitory activity against α-glucosidase, aldose reductase, α-amylase, and lipase. The flavonoids also showed mild inhibition on α-glucosidase, aldose reductase, α-amylase and lipase.
CONCLUSIONS: The results demonstrate that Jinqi Jiangtang Tablet can scavenge free radicals and inhibit α-glucosidase, aldose reductase, α-amylase and lipase, which may be the possible mechanism of action of Jinqi Jiangtang Tablet for the treatment of diabetes and associated complications. Compared with conventional chromatographic separation and activity assays, the multi-targets integrated fingerprinting, which simultaneously contains the chemical characteristics and multiple effects of constitutions could comprehensively and properly reveal the activity of Jinqi Jiangtang Tablet. The results also show that the multi-targets integrated fingerprinting is a novel and powerful tool for screening and identifying active ingredients from Traditional Chinese Medicines.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Alkaloids; Berberine (PubChem CID: 2353); Chlorogenic acid (PubChem CID: 1794427); Coptisine (PubChem CID: 72322); Epiberberine (PubChem CID: 160786); Flavonoids; Isochlorogenic acid C (PubChem CID: 6474309); Jatrorrhizin (PubChem CID: 72323); Jinqi Jiangtang Tablet; Multi-targets integrated fingerprinting; Neochlorogenic acid (PubChem CID: 5280633); Palmatine (PubChem CID: 19009); Phenolic acids; Quercetin (PubChem CID: 5280343); Rutin (PubChem CID: 5280805); UHPLC/Q-TOF-MS/FC-MR

Mesh:

Substances:

Year:  2015        PMID: 25698248     DOI: 10.1016/j.jep.2015.02.018

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  11 in total

Review 1.  Antidiabetic Potential of Medicinal Plants and Their Active Components.

Authors:  Bahare Salehi; Athar Ata; Nanjangud V Anil Kumar; Farukh Sharopov; Karina Ramírez-Alarcón; Ana Ruiz-Ortega; Seyed Abdulmajid Ayatollahi; Patrick Valere Tsouh Fokou; Farzad Kobarfard; Zainul Amiruddin Zakaria; Marcello Iriti; Yasaman Taheri; Miquel Martorell; Antoni Sureda; William N Setzer; Alessandra Durazzo; Massimo Lucarini; Antonello Santini; Raffaele Capasso; Elise Adrian Ostrander; Muhammad Iqbal Choudhary; William C Cho; Javad Sharifi-Rad
Journal:  Biomolecules       Date:  2019-09-30

2.  Refined-JinQi-JiangTang tablet ameliorates hypertension through activation of FGF21/FGFR1 axis in fructose-fed rats.

Authors:  Siming Li; Xiaoling Li; Jing Fan; Xinhang Jia; Hemeng Wang; Fangxin Dong; Haoyang Mao; Chen Zhang; Wenfei Wang; Ye Jiang; Lijun Yan; Na Zhang
Journal:  J Nat Med       Date:  2022-05-09       Impact factor: 3.192

3.  Screening In Vitro Targets Related to Diabetes in Herbal Extracts from Peru: Identification of Active Compounds in Hypericum laricifolium Juss. by Offline High-Performance Liquid Chromatography.

Authors:  Yanymee N. Guillen Quispe; Seung Hwan Hwang; Zhiqiang Wang; Guanglei Zuo; Soon Sung Lim
Journal:  Int J Mol Sci       Date:  2017-11-24       Impact factor: 5.923

4.  Development and Validation of an UPLC-MS/MS Method for Pharmacokinetic Comparison of Five Alkaloids from JinQi Jiangtang Tablets and Its Monarch Drug Coptidis Rhizoma.

Authors:  Lili Sun; Feifei Ding; Guangjiao You; Han Liu; Meng Wang; Xiaoliang Ren; Yanru Deng
Journal:  Pharmaceutics       Date:  2017-12-29       Impact factor: 6.321

5.  JinQi Jiangtang Tablet Regulates Gut Microbiota and Improve Insulin Sensitivity in Type 2 Diabetes Mice.

Authors:  Ying Cao; Guowang Yao; Yuanyuan Sheng; Li Yang; Zixuan Wang; Zhen Yang; Pengwei Zhuang; Yanjun Zhang
Journal:  J Diabetes Res       Date:  2019-01-10       Impact factor: 4.011

6.  Based on Multi-Activity Integrated Strategy to Screening, Characterization and Quantification of Bioactive Compounds from Red Wine.

Authors:  Yuye Gao; Xie-An Yu; Bing Wang; Guo Yin; Jue Wang; Tiejie Wang; Kaishun Bi
Journal:  Molecules       Date:  2021-11-08       Impact factor: 4.411

7.  Effects of Chinese herbal medicines on the occurrence of diabetic retinopathy in type 2 diabetes patients and protection of ARPE-19 retina cells by inhibiting oxidative stress.

Authors:  Fuu-Jen Tsai; Te-Mao Li; Cheng-Hang Ko; Wen-Miin Liang; Ying-Ju Lin; Chi-Fung Cheng; Tsung-Jung Ho; Xiang Liu; Hsinyi Tsang; Ting-Hsu Lin; Chiu-Chu Liao; Ju-Pi Li; Shao-Mei Huang; Jung-Chun Lin; Chih-Chien Lin
Journal:  Oncotarget       Date:  2017-06-29

8.  Hypoglycemic Efficacy of Docking Selected Natural Compounds against α-Glucosidase and α-Amylase.

Authors:  Jirawat Riyaphan; Chien-Hung Jhong; Shian-Ren Lin; Chia-Hsiang Chang; May-Jwan Tsai; Der-Nan Lee; Ping-Jyun Sung; Max K Leong; Ching-Feng Weng
Journal:  Molecules       Date:  2018-09-05       Impact factor: 4.411

9.  The emergence of a functionally flexible brain during early infancy.

Authors:  Weiyan Yin; Tengfei Li; Sheng-Che Hung; Han Zhang; Li Wang; Dinggang Shen; Hongtu Zhu; Peter J Mucha; Jessica R Cohen; Weili Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-31       Impact factor: 11.205

10.  Obese rats intervened with Rhizoma coptidis revealed differential gene expression and microbiota by serum metabolomics.

Authors:  Yanhua Ji; Kexin Luo; Jiri Mutu Zhang; Peng Ni; Wangping Xiong; Xiaoquan Luo; Guoliang Xu; Hongning Liu; Zhijun Zeng
Journal:  BMC Complement Med Ther       Date:  2021-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.